Pursuant to section
4729.75
of the Revised Code, required information for the
following list of drugs pursuant to an outpatient
prescription, personally furnished by a prescriber, or sold at wholesale to a
prescriber or a terminal distributor of dangerous drugs shall be
submitted to the board of pharmacy pursuant to sections
4729.77,
4729.78
and
4729.79
of the Revised Code:

The following entities are required to submit the specified
dispensing, personal furnishing, or wholesale sale information to the board of
pharmacy for the drug database:

(A)
All pharmacies located outside this state and licensed as a terminal
distributor of dangerous drugs shall report all drugs identified in
rules
4729-37-02 and 4729-37-12 of the Administrative
Code that are dispensed to outpatients residing in this state.

(B)
All pharmacies located within this state
and licensed as a terminal distributor of dangerous drugs shall report all
drugs identified in rules 4729-37-02 and
4729-37-12 of the Administrative Code that are dispensed to all
outpatients.

(C)
All wholesalers
licensed as a wholesale distributor of dangerous drugs that sell drugs
identified in rules 4729-37-02 and
4729-37-12 of the Administrative Code at wholesale shall report those
drug transactions.

(D)
All
pharmacies licensed as a terminal distributor of dangerous drugs that sell
drugs identified in rules 4729-37-02 and
4729-37-12 of the Administrative Code at wholesale shall report those
drug transactions.

(E)
All
prescribers, except veterinarians, located within this state shall report all
drugs identified in rules 4729-37-02 and
4729-37-12 of the Administrative Code that are personally furnished to
outpatients.

(A)
Pharmacies pursuant to paragraphs (A) and
(B) of rule
4729-37-03
of the Administrative Code that dispense drugs identified in rules
4729-37-02
and
4729-37-12
of the Administrative Code to outpatients residing in this state must report
the following dispensing information to the board of pharmacy:

(22)
Prescriber's national provider
identification (NPI) number, unless the prescriber is a licensed veterinarian
as defined in section
4741.01
of the Revised Code; and

(23)
Any of the following as indicated by the prescriber
pursuant to rule
4729-5-30
of the Administrative Code:

(a)
The ICD-10-CM medical diagnosis code of the primary
disease or condition that the controlled substance drug is being used to treat.
The code shall, at a minimum, include the first four characters of the
ICD-10-CM medical diagnosis code, sometimes referred to as the category and the
etiology (ex. M 16.5 );

(b)
For dentists licensed pursuant to Chapter 4715. of the
Revised Code, the Code on Dental Procedures and Nomenclature (CDT Code), as
published by the American dental association, of the dental treatment requiring
the controlled substance prescription;

(c)
If no such code
is indicated on the prescription, the pharmacy shall indicate "NC" in the
diagnosis data field.

(B)
Prescribers pursuant to paragraph (E) of
rule
4729-37-03
of the Administrative Code that personally furnish drugs identified in rules
4729-37-02
and
4729-37-12
of the Administrative Code to outpatients must report the following
information to the board of
pharmacy:

(a)
The ICD-10-CM medical diagnosis code of the primary disease
or condition that the controlled substance drug is being used to treat. The
code shall, at a minimum, include the first four characters of the ICD-10-CM
medical diagnosis code, sometimes referred to as the category and the etiology
(ex. M 16.5 );

(b)
For dentists licensed pursuant to Chapter 4715. of the
Revised Code, the Code on Dental Procedures and Nomenclature (CDT Code), as
published by the American dental association, of the dental treatment requiring
the controlled substance prescription.

(C)
Wholesalers and pharmacies pursuant to
paragraphs (C) and (D) of rule
4729-37-03
of the Administrative Code that sell drugs identified in rules
4729-37-02
and
4729-37-12
of the Administrative Code at wholesale must at least report the following
information to the board of pharmacy in the format described in rule
4729-37-06
of the Administrative Code:

(A)
All pharmacy dispensing information or prescriber personally furnishing
information required to be submitted to the board of pharmacy pursuant to rule
4729-37-04
of the Administrative Code must be transmitted in the following format specified by the "American Society
for Automation in Pharmacy" (ASAP) for prescription monitoring programs:

(B)
In the event that a pharmacy or a prescriber cannot electronically transmit the
required information pursuant to rule
4729-37-04
of the Administrative Code, the pharmacy or
prescriber shall immediately contact the board of pharmacy
to determine a mutually acceptable method of reporting. The pharmacy or
prescriber must document in writing to the board of pharmacy the reasons for
the
inability to submit the required information.

(A)
All wholesale data required to be submitted to the board of pharmacy pursuant
to paragraph (B) of rule
4729-37-04
of the Administrative Code must be transmitted in the report format used when
transmitting controlled substance data to the federal drug enforcement
administration via the "Automation of Reports and Consolidated Orders System
(ARCOS)" or other mutually acceptable format.

(B)
In the event that a wholesaler or
pharmacy cannot electronically transmit the required information pursuant to
paragraph (B) of rule
4729-37-04
of the Administrative Code they must immediately contact the board of pharmacy
to determine a mutually acceptable method of reporting. The wholesaler or
pharmacy must document in writing to the board of pharmacy the reasons for
their inability to submit the required information.

(A)
A
pharmacy or prescriber that has possessed for the purpose of dispensing or
personally furnishing a reported drug (including a sample drug) within the
previous two years shall submit to the board of pharmacy, at least daily,
either of the following:

(1)
All drug
dispensing and personally furnishing information required to be submitted to
the board of pharmacy pursuant to rules
4729-37-02, 4729-37-12 and 4729-37-04 of the Administrative
Code.

(2)
A "Zero Report", if a
pharmacy has no drug dispensing information or a prescriber has no personally
furnishing information required to be submitted to the board of pharmacy
pursuant to rules
4729-37-02, 4729-37-12 and 4729-37-04 of the Administrative
Code.

(B)
The dispensing
report, the personally furnishing information, or the "Zero Report" shall be
consecutive and inclusive from the last date and time that information was
submitted and shall be reported no later than thirty-six hours after the last
time reported on a previous report.

(C)
Any record of a dispensed or personally
furnished reportable drug shall be reported to the board of pharmacy within
twenty-four hours of being dispensed or personally furnished.

(D)
Any pharmacy or prescriber whose normal
business hours are not seven days per week shall electronically indicate their
normal business hours to the board and a "Zero Report" will be automatically
submitted on their behalf on non-business days.

(E)
If a pharmacy or prescriber ceases to
possess for the purpose of dispensing or personally furnishing any reported
drug (including a sample drug), the responsible person shall notify the board
of pharmacy electronically or in writing. The board shall be notified if the
pharmacy or prescriber resumes dispensing or personally furnishing a reportable
drug, including a sample drug.

(F)
All wholesale drug sale information required to be submitted to the board of
pharmacy pursuant to rules
4729-37-02, 4729-37-12 and 4729-37-04 of the Administrative Code
must be submitted monthly as follows:

(2)
The information shall be consecutive and
inclusive from the last date and time information was submitted and shall be
reported no later than forty-five days after the date of the wholesale
sale.

(G)
In the event
that a wholesaler, prescriber, or pharmacy cannot submit the required
information as described in this rule, the responsible person must immediately
contact the board of pharmacy to determine a mutually acceptable time for
submission of information. The reasons for the inability of the wholesaler,
prescriber, or pharmacy to submit the required information must be documented
in writing to the board of pharmacy.

(1)
Complete a request form
giving such information as required by the board of pharmacy that will include
an active case number assigned by the investigating agency or department and an
approval by a supervisor of that agency or department;

(2)
Submit the completed form to the board of
pharmacy in person, by mail, or by other board approved means.

(C)
An individual seeking the
individual's own database information must:

(1)
Complete a notarized request form giving
such information as required by the board of pharmacy;

(3)
Receive the information
in person at the board of pharmacy office during normal business hours and show
proof of identity with a current government issued form of identification that
contains a picture such as a current state issued identification card, a
current state issued driver's license, or a valid passport;

(4)
Pay the cost of printing the document as
determined by the board of pharmacy's current per page rate.

A government entity or a law enforcement agency pursuant to
section 4729.82 of the Revised Code may request that specific information in the
database related to an open investigation be retained beyond the
three year
information retention requirement. The government entity or law enforcement
agency must submit a written request on a form giving such information as
required by the board of pharmacy.

The board of pharmacy may provide or present database
statistics and law enforcement outcomes based on request information pursuant
to section
4729.79
of the Revised Code. The information shall not identify a person and will be
provided as determined by the board of pharmacy in summary, statistical, or
aggregate form.

(A)
Drug dispensing and wholesale drug sale
information must be submitted to the drug database in an accurate and timely
manner pursuant to rule
4729-37-07
of the Administrative Code.

(B)
If
the omission of drug dispensing or wholesale drug sale
information is discovered, the omitted information must be submitted to the
board of pharmacy by the pharmacy, prescriber, or wholesaler during the next
reporting time period after the discovery.

(C)
If erroneous drug dispensing or wholesale
drug sale information is discovered, the corrected information must be
submitted to the board of pharmacy by the pharmacy, prescriber or wholesaler
during the next reporting time period after the discovery.

(D)
If the
omission of data or erroneous data is the result of a computer programming
error, the pharmacy, prescriber, or wholesaler must notify the board of
pharmacy immediately by telephone and submit written documentation. The
documentation shall fully describe the error and propose a date for submitting
the corrected drug information. The board will review the written documentation
to assure compliance with paragraph (A) of this rule.

(E)
Except as noted
in paragraph (D) of this rule, all data must be submitted or corrected
electronically unless prior permission for an alternate method is approved by
the board of pharmacy.

Pursuant to section
4729.75
of the Revised Code, the required information for the following list of drugs
pursuant to an outpatient prescription, personally furnished by a prescriber,
or sold at wholesale to a prescriber or a terminal distributor of dangerous
drugs shall be submitted to the state board of pharmacy in accordance with
sections
4729.77,
4729.78
and
4729.79
of the Revised Code: